Trials / Recruiting
RecruitingNCT06906627
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 750 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Detailed description
IRIS-CKD Screening Program: will focus on CKD screening in T2D. We will identify patients with T2D that have not received appropriate screening for CKD within the last 15 months and randomize patients to receive either a home kit to complete CKD screening ("home kit") versus a standard laboratory order ("laboratory order"). The primary objective is to evaluate whether delivery of home testing kits versus standard laboratory testing influences the degree to which patients receive guideline-recommended CKD screening. Patients will complete approximately 3 months of follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | (IRIS-CKD Screening Program): Home Kit | All participants approached for enrollment in Program 1 will receive National Kidney Foundational educational materials related to CKD screening in type 2 diabetes and study information. All enrolled participants will receive a message regarding study lab(s) results. Home Test Kit: a kit delivered to participants homes with instructions to complete eGFR (fingerstick) and/or UACR (urine sample) testing, depending on which lab(s) are missing at baseline. |
| OTHER | (IRIS-CKD Screening Program): Standard Lab Order | ll participants approached for enrollment in Program 1 will receive National Kidney Foundation educational materials related to CKD screening in type 2 diabetes and study information. All enrolled participants will receive a message regarding study lab |
Timeline
- Start date
- 2025-10-28
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2025-04-02
- Last updated
- 2026-04-08
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06906627. Inclusion in this directory is not an endorsement.